Sensus Healthcare (SRTS) announces that the company has resumed purchasing shares of its common stock in open-market transactions under a $3.0 million share repurchase program approved by its ...

In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Sensus Healthcare (SRTS – Research Report), with a price target of $14.00. The company’s shares ...

Revenue: US$41.8m (up 71% from FY 2023). Net income: US$6.65m (up by US$6.16m from FY 2023). Profit margin: 16% (up from 2.0% in FY 2023). The increase in margin was driven by higher revenue. EPS ...

BOCA RATON, Fla., February 05, 2025--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost ...

On February 5, Sensus shared the financial statements corresponding to its full year 2024. At first glance, we can notice a surprise in sales compared to what analysts expected. Specifically ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Xylem Inc. (XYL) on Tuesday ...

The global Smart Water Meters Market is anticipated to grow from estimated USD 4.61 billion in 2024 to USD 9.04 billion by 2030, at a CAGR of ...

Sensus, a Xylem brand that focuses on cutting-edge technology solutions for utilities and public-sector service providers, is an industry giant in metering solutions for water, gas, electric ...